You can bill 2-hour esketamine code with therapy, and with prolonged codes
Effective May 18, 2023
Published May 22, 2023
Last Reviewed May 18, 2023
Question: Our psychiatric provider will administer Spravato (esketamine) to a patient. I know there are codes for this: G2082 (Office E/M, established patient, w/provision of up to 56 mg of esketamine nasal self-administration, includes 2 hours post-administration observation) and G2083 (... ; greater than 56 mg esketamine). But could we use other E/M codes with prolonged services instead? Also, psychotherapy may be performed prior to giving the medication — can we bill that? And should we report the drug separately?
You must log in to view the content you requested.
Not a subscriber? Start accessing the article you’re seeking right away plus weekly, physician practice-specific news, analysis, guidance and specific tools that enable your practice to stay compliant and profitable during times of increased regulatory scrutiny.
Need multi-user access? Ensure uninterrupted individual access and maximum coding productivity for your whole team. For site license inquiries call: 1-855-CALL-DH1
Part B News is how you level the playing field and take control of the financial impact that the changing health care landscape has on your practice. When you subscribe to Part B News, you get step-by-step instructions from the nation's leading physician practice management experts on how to not just survive – but thrive – from changes at CMS and private payers. Plus, through this web site and its forums, you plug into a community of peers who'll share exactly what's working and what's not as questions arise in your practice.
A subscription to Part B News is the physician practice manager’s best tool to ensure that your practice collects every dollar it deserves. Our $25,000 guarantee ensures that your subscription will pay for itself at least 50 times over or we will refund the full year’s subscription fee.
To learn more about subscribing to Part B News, visit the DecisionHealth store right now.